Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol Gel for Prophylaxis After PRK
NCT03123614Phase 4Completed
- Sponsor
- University of Utah
- Start
- Sep 2014
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of loteprednol etabonate ophthalmic gel 0.38% in corneal haze (2 arms), sponsored by University of Utah. Primary endpoint: Change in Intraocular Pressure From Baseline Through Month 3. Started Sep 2014; status: completed.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
corneal haze
Beyond the preview
Go deeper on NCT03123614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123614.